Abstract
This work is focused on determining whether two graphene derivatives: graphene oxide (GO) and reduced graphene oxide (RGO) can be used alone as a component of anticancer therapy. In this paper, we present the synthesis GO and RGO, their physicochemical characterization as well as an evaluation of their cytotoxic properties on cancer (HepG2 and MCF-7) and non-malignant (clone-9 and HMF) cells. We demonstrated that both tested graphene derivatives have a high affinity to cancer cells. We showed that cytotoxic properties of GO and RGO were different depending on the type of solvent in which they were prepared. Additionally, we observed that cytotoxic properties of GO and RGO were different depending on the origin of the cells (liver and breast) and the form of graphene material (GO and RGO). We showed that GO and RGO can be potential, selectively materials which in future can found application in anticancer therapy.
Similar content being viewed by others
References
T.Y. Zakharian, A. Seryshev, B. Sitharaman, B.E. Gilbert, V. Knight, and L.J. Wilson: A fullerene−paclitaxel chemotherapeutic: Synthesis, characterization, and study of biological activity in tissue culture. J. Am. Chem. Soc. 127, 12508 (2005).
Z. Liu, S. Tabakman, K. Welsher, and H. Dai: Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery. Nano Res. 2, 85 (2009).
A.M. Pinto, I.C. Gonçalves, and F.D. Magalhães: Graphene-based materials biocompatibility: A review. Colloids Surf. B 111, 188 (2013).
D. Bitounis, A. Boucetta, B.H. Hong, D.H. Min, and K. Kostarelos: Prospects and challenges of graphene in biomedical applications. Adv. Mater. 25, 2258 (2013).
Z.M. Markovic, L.M. Harhaji-Trajkovic, B.M. Todorovic-Markovic, D.P. Kepi, K.M. Arsikin, S.P. Jovanovi, A.C. Pantovic, M.D. Dramicanin, and V.S. Trajkovic: In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes. Biomaterials 32, 1121 (2011).
J.T. Robinson, S.M. Tabakman, Y. Liang, H. Wang, H.S. Casalongue, D. Vinh, and H. Dai: Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J. Am. Chem. Soc. 133, 6825 (2011).
P. Huang, C. Xu, J. Lin, C. Wang, X. Wang, C. Zhang, X. Zhou, S. Guo, and D. Cui: Folic acid-conjugated graphene oxide loaded with photosensitizers for targeting photodynamic therapy. Theranostics 1, 240 (2011).
B. Tian, C. Wang, S. Zhang, L. Feng, and Z. Liu: Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ASC Nano 5, 7000 (2011).
L. Zhang, Z. Lu, Q. Zhao, J. Huang, H. Shen, and Z. Zhang: Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI-grafted graphene oxide. Small 7, 460 (2011).
Z. Xu, S. Wang, Y. Li, M. Wang, P. Shi, and X. Huang: Covalent functionalization of graphene oxide with biocompatible poly(ethylene glycol) for delivery of paclitaxel. ACS Appl. Mater. Interfaces 6, 17268 (2014).
S. Bengtson, K. Kling, A.M. Madsen, A.W. Noergaard, N.R. Jacobsen, P.A. Clausen, B. Alonso, A. Pesquera, A. Zurutuz, R. Ramos, H. Okuno, J. Dijon, H. Wallin, and U. Vogel: No cytotoxicity or genotoxicity of graphene and graphene oxide in murine lung epithelial FE1 cells in vitro. Environ. Mol. Mutagen. 57, 469 (2016).
S.A. Loutfy, T.A. Salaheldin, M.A. Ramadan, K.Y. Farroh, Z.F. Abdallah, and T. Youssef: Synthesis, characterization and cytotoxic evaluation of graphene oxide nanosheets: In vitro liver cancer model. Asian Pac. J. Cancer Prev. 18, 955 (2017).
J. Wu, R. Yang, L. Zhang, Z. Fan, and S. Liu: Cytotoxicity effect of graphene oxide on human MDA-MB-231 cells. Toxicol. Mech. Methods 25, 312 (2015).
T.A. Tabish, M.Z. Pranjol, H. Hayat, A.A.M. Rahat, T.M. Abdullah, J.L. Whatmore, and S. Zhang: In vitro toxic effects of reduced graphene oxide nanosheets on lung cancer cells. Nanotechnology 15, 504001 (2017).
L. Luo, L. Xu, and H. Zhao: Biosynthesis of reduced graphene oxide and its in-vitro cytotoxicity against cervical cancer (HeLa) cell lines. Mater. Sci. Eng. C 78, 198 (2017).
T. Zhou, B. Zhang, P. Wei, Y. Du, H. Zhou, M. Yu, L. Yan, W. Zhang, G. Nie, C. Chen, Y. Tu, and T. Wei: Energy metabolism analysis reveals the mechanism of inhibition of breast cancer cell metastasis by PEG-modified graphene oxide nanosheets. Biomaterials 37, 9833 (2014).
C.N. Yeh, K. Raidongia, J. Shao, Q.H. Yang, and J. Huang: On the origin of the stability of graphene oxide membranes in water. Nat. Chem. 7, 166 (2015).
D. Li, M.B. Müller, S. Gilje, R.B. Kaner, and G.G. Wallace: Processable aqueous dispersions of graphene nanosheets. Nat. Nanotechnol. 3, 101 (2008).
S. Gurunathan, J.W. Han, V. Eppakayala, and J.H. Kim: Green synthesis of graphene and its cytotoxic effects in human breast cancer cells. J. Nanomed. 8, 1015 (2013).
N.S. Chaudhari, A.P. Pandey, P.O. Patil, A.R. Tekade, S.B. Bari, and P.K. Deshmukh: Graphene oxide based magnetic nanocomposites for efficient treatment of breast cancer. Mater. Sci. Eng. C 37, 278 (2014).
N. Chatterjee, H.J. Eom, and J. Choi: A systems toxicology approach to the surface functionality control of graphene-cell interactions. Biomaterials 35, 1109 (2014).
S. Das, S. Singh, V. Singh, D. Joung, J.M. Dowding, D. Reid, J. Anderson, L. Zhai, S.I. Khondaker, W.T. Self, and S. Seal: Oxygenated functional group density on graphene oxide: Its effect on cell toxicity. Part. Part. Syst. Charact. 30, 148 (2013).
N.V. Vallabani, S. Mittal, R.K. Shukla, A.K. Pandey, S.R. Dhakate, R. Pasricha, and A. Dhawan: Toxicity of graphene in normal human lung cells (BEAS-2B). J. Biomed. Nanotechnol. 7, 106 (2011).
A. Wang, K. Pu, B. Dong, Y. Liu, L. Zhang, Z. Zhang, W. Duan, and Y. Zhu: Role of surface charge and oxidative stress in cytotoxicity and genotoxicity of graphene oxide towards human lung fibroblast cells. J Appl. Toxicol. 33, 1156 (2013).
S. Fulda, A.M. Gorman, O. Hori, and A. Samali: Cellular stress responses: Cell survival and cell death. Int. J. Cell Biol. (2010). doi:10.1155/2010/214074.
V.C. Sanchez, A. Jachak, R.H. Hurt, and A.B. Kane: Biological interactions of graphene-family nanomaterials–An interdisciplinary review. Chem. Res. Toxicol. 25, 15 (2012).
A. Fletcher: The cell membrane and receptors. Anaesth. Intensive Care Med. 18, 316 (2017).
W.S. Hummers and R.E. Offeman: Preparation of graphitic oxide. J. Am. Chem. Soc. 80, 1339 (1958).
J. Zhang, H. Yang, G. Shen, P. Cheng, J. Zhang, and S. Guo: Reduction of graphene oxide via L-ascorbic acid. Chem. Commun. 46, 1112 (2010).
Acknowledgment
This work was financially supported within a frame of OPUS 11 program No. UMO-2016/21/B/ST5/01774.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zuchowska, A., Dabrowski, B., Jastrzebska, E. et al. Cytotoxic properties of graphene derivatives depending on origin and type of cell line. Journal of Materials Research 35, 2385–2395 (2020). https://doi.org/10.1557/jmr.2020.201
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1557/jmr.2020.201